Suspected Substance Withdrawal in Adolescents Clinical Pathway — Inpatient
Suspected Substance Withdrawal in Adolescents Clinical Pathway — Inpatient
Withdrawal from Other Commonly Misused Substances
- Consult Poison Control Center for monitoring and symptom management recommendations if concerns for withdrawal symptoms. CHOP clinicians, call 4-2100.
- Cannabis, nicotine and stimulants are the most commonly reported use-disorders in adolescents with treatment options for withdrawal
- Xylazine is included because it is commonly associated with illicit opioid use
- Utilize routine patient monitoring practices
Substance | Signs, Symptoms of Withdrawal | Resources for Management |
---|---|---|
THC/Cannabis |
|
Consult Psychiatry for agitation plan |
Nicotine |
|
|
Stimulants e.g., cocaine, amphetamines, caffeine |
|
Consult Psychiatry for agitation plan |
Xylazine |
|
Consult Psychiatry for agitation plan |
Anticholinergics e.g., diphenhydramine |
|
Consult Psychiatry for agitation plan |
Other e.g., PCP, dextromethorphan |
Dextromethorphan
|
Consult Psychiatry for agitation plan |